2024 6-month group forecast
Nov 1 (Reuters) -
Sapporo Clinical Laboratory Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
6 Months to 6 Months to
Sep 30, 2024 Sep 30, 2024
LATEST PREVIOUS
FORECAST FORECAST
Sales 10.00 9.80
Operating 337 mln 221 mln
Recurring 343 mln 226 mln
Net 222 mln 141 mln
EPS 71.05 yen 45.13 yen
NOTE - Sapporo Clinical Laboratory Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T
Recent news on Sapporo Clinical Laboratory
See all newsTable: Sapporo Clinical Lab - 9-MTH group results
Table: Sapporo Clinical Lab - 6-MTH group results
Brief: Sapporo Clinical Laboratory Inc - To Retire Treasury Shares Worth 26% Of Outstanding Stock On Feb 17
Table: Sapporo Clinical Lab -Q1 group results
Table: Sapporo Clinical Lab -2024/25 parent results